HK1205558A1 - Methods and biomarkers for detection and prognosis of cervical cancer - Google Patents

Methods and biomarkers for detection and prognosis of cervical cancer

Info

Publication number
HK1205558A1
HK1205558A1 HK15106025.9A HK15106025A HK1205558A1 HK 1205558 A1 HK1205558 A1 HK 1205558A1 HK 15106025 A HK15106025 A HK 15106025A HK 1205558 A1 HK1205558 A1 HK 1205558A1
Authority
HK
Hong Kong
Prior art keywords
biomarkers
prognosis
detection
methods
cervical cancer
Prior art date
Application number
HK15106025.9A
Other languages
English (en)
Chinese (zh)
Inventor
Heidi Lyng
Cathinka Halle Julin
Original Assignee
Univ Oslo Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oslo Hf filed Critical Univ Oslo Hf
Publication of HK1205558A1 publication Critical patent/HK1205558A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7038—Hypoxia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK15106025.9A 2012-02-21 2015-06-24 Methods and biomarkers for detection and prognosis of cervical cancer HK1205558A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261601194P 2012-02-21 2012-02-21
PCT/IB2013/000664 WO2013124738A2 (en) 2012-02-21 2013-02-20 Methods and biomarkers for detection and prognosis of cervical cancer

Publications (1)

Publication Number Publication Date
HK1205558A1 true HK1205558A1 (en) 2015-12-18

Family

ID=48325786

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106025.9A HK1205558A1 (en) 2012-02-21 2015-06-24 Methods and biomarkers for detection and prognosis of cervical cancer

Country Status (5)

Country Link
US (1) US9506117B2 (xx)
EP (1) EP2817627A2 (xx)
CN (1) CN104220876A (xx)
HK (1) HK1205558A1 (xx)
WO (1) WO2013124738A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2817627A2 (en) 2012-02-21 2014-12-31 Oslo Universitetssykehus HF Methods and biomarkers for detection and prognosis of cervical cancer
WO2015107430A2 (en) 2014-01-16 2015-07-23 Oslo Universitetssykehus Hf Methods and biomarkers for detection and prognosis of cervical cancer
CN106701801B (zh) * 2017-02-17 2021-07-23 复旦大学 B淋巴瘤和白血病的检测标记物、试剂盒及其应用
CN109743229A (zh) * 2019-01-11 2019-05-10 武汉斗鱼鱼乐网络科技有限公司 基于分布式的性能测试方法、装置和系统
MX2019005940A (es) * 2019-05-21 2019-10-11 Atso Corp Affairs S A De C V Biomarcadores relacionados a cancer.
CN112176065A (zh) * 2020-08-20 2021-01-05 中国医学科学院北京协和医院 用于宫颈癌预后或预测宫颈癌复发或转移风险的试剂和方法
CN114966060A (zh) * 2022-07-14 2022-08-30 浙江省肿瘤医院 一种胃癌预后生物标志物及其应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
ATE88761T1 (de) 1986-01-10 1993-05-15 Amoco Corp Kompetitiver homogener test.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5225326A (en) 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay
US5639611A (en) 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
ATE141956T1 (de) 1989-07-11 1996-09-15 Gen Probe Inc Verfahren zur vervielfältigung von nukleinsäuresequenzen
CA2036946C (en) 1990-04-06 2001-10-16 Kenneth V. Deugau Indexing linkers
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US5545524A (en) 1991-12-04 1996-08-13 The Regents Of The University Of Michigan Compositions and methods for chromosome region-specific probes
US5338671A (en) 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5714330A (en) 1994-04-04 1998-02-03 Lynx Therapeutics, Inc. DNA sequencing by stepwise ligation and cleavage
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
JP3189000B2 (ja) 1994-12-01 2001-07-16 東ソー株式会社 特定核酸配列の検出方法
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US5710029A (en) 1995-06-07 1998-01-20 Gen-Probe Incorporated Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US6121489A (en) 1996-03-05 2000-09-19 Trega Biosciences, Inc. Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
CA2252048C (en) 1996-04-12 2008-03-11 The Public Health Research Institute Of The City Of New York, Inc. Detection probes, kits and assays
US5770370A (en) 1996-06-14 1998-06-23 David Sarnoff Research Center, Inc. Nuclease protection assays
CA2283267A1 (en) 1997-03-07 1998-09-11 Clare Chemical Research Llc Fluorometric detection using visible light
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6511803B1 (en) 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6432360B1 (en) 1997-10-10 2002-08-13 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
ATE440963T1 (de) 1998-07-02 2009-09-15 Gen Probe Inc Molekulare fackeln
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6573043B1 (en) 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
US6303305B1 (en) 1999-03-30 2001-10-16 Roche Diagnostics, Gmbh Method for quantification of an analyte
DE60014762T2 (de) 1999-05-24 2005-10-13 Tosoh Corp., Shinnanyo Methode zum Nachweis von Ribonukleinsäuren
WO2001023610A2 (en) 1999-09-29 2001-04-05 Solexa Ltd. Polynucleotide sequencing
AR031640A1 (es) 2000-12-08 2003-09-24 Applied Research Systems Amplificacion isotermica de acidos nucleicos en un soporte solido
ATE309393T1 (de) 2001-09-06 2005-11-15 Adnagen Ag Verfahren zum qualitativen und/oder quantitativen nachweis von zellen
US7081339B2 (en) 2002-04-12 2006-07-25 Primera Biosystems, Inc. Methods for variation detection
KR101086611B1 (ko) 2002-06-20 2011-11-23 프리메라디엑스, 인크. 폴리뉴클레오티드 감지와 정량을 위한 기구
DE60335116D1 (de) 2002-06-28 2011-01-05 Primeradx Inc Verfahren zum nachweis von sequenzunterschieden
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
EP2159285B1 (en) 2003-01-29 2012-09-26 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
US8679789B2 (en) 2003-05-01 2014-03-25 Gen-Probe Incorporated Oligonucleotides comprising a molecular switch
AU2004270220B2 (en) 2003-09-05 2009-03-05 The Chinese University Of Hong Kong Method for non-invasive prenatal diagnosis
US7319011B2 (en) * 2004-04-08 2008-01-15 Duke University Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
DE602005026730D1 (de) 2004-08-27 2011-04-14 Gen Probe Inc Einfach-Primernukleinsäuren-Erweiterungsverfahren
EP2233581A1 (en) 2005-02-01 2010-09-29 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
KR100943525B1 (ko) 2005-03-18 2010-02-22 (주)지노믹트리 바이오마커 스크리닝 시스템
ES2374788T3 (es) 2005-12-23 2012-02-22 Nanostring Technologies, Inc. Nanoinformadores y métodos para su producción y uso.
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
EP2423334A3 (en) 2006-02-02 2012-04-18 The Board of Trustees of The Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
US20080076121A1 (en) 2006-09-22 2008-03-27 Paul Kenneth Wolber Microarray nuclease protection assay
US20100216131A1 (en) * 2006-12-11 2010-08-26 Rajyalakshmi Luthra Gene expression profiling of esophageal carcinomas
JP5555157B2 (ja) 2007-04-10 2014-07-23 ナノストリング テクノロジーズ， インコーポレイテッド ナノレポーターにおける使用のための標的特異的配列を同定するための方法およびコンピュータシステム
US8519115B2 (en) 2008-08-14 2013-08-27 Nanostring Technologies, Inc. Stable nanoreporters
CA2778249C (en) 2009-11-03 2018-12-04 Htg Molecular Diagnostics, Inc. Quantitative nuclease protection sequencing (qnps)
GB0922437D0 (en) * 2009-12-22 2010-02-03 Cancer Rec Tech Ltd Hypoxia tumour markers
US20110224088A1 (en) 2010-03-11 2011-09-15 Heidi Lyng Biomarkers for subtypes of cervical cancer
US20140026234A1 (en) * 2011-01-28 2014-01-23 Thomas Jefferson University Biomarkers and their uses in cancer detection and therapy
EP2817627A2 (en) 2012-02-21 2014-12-31 Oslo Universitetssykehus HF Methods and biomarkers for detection and prognosis of cervical cancer

Also Published As

Publication number Publication date
US9506117B2 (en) 2016-11-29
WO2013124738A3 (en) 2014-01-23
CN104220876A (zh) 2014-12-17
US20150018242A1 (en) 2015-01-15
EP2817627A2 (en) 2014-12-31
WO2013124738A2 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
IL254255A0 (en) A method for predicting the likelihood of clinical outcome for a patient with prostate cancer
HK1212932A1 (zh) 用於檢測和獲取生物標誌物的方法和裝置
EP2847593A4 (en) METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER
HK1206431A1 (en) Method for the prognosis and treatment of cancer metastasis
EP2804960A4 (en) BREAST CANCER BIOMARK SIGNATURES FOR INVASIVITY AND FORECAST
EP2917734A4 (en) SYSTEM AND METHOD FOR DETECTION OF CANCER BASED ON SERUM
HK1259001A1 (zh) 癌症的預後和診斷方法
SG10201703022SA (en) Method of prognosis and stratification of ovarian cancer
GB201320061D0 (en) Materials nad methods for diagnosis and prognosis of liver cancer
HK1205558A1 (en) Methods and biomarkers for detection and prognosis of cervical cancer
IL230303B (en) Methods and nucleic acids for determining the prognosis of a cancer patient
HK1204016A1 (en) Methods and kits for detecting subjects at risk of having cancer
HK1206414A1 (en) Biomarkers for gastric cancer and uses thereof
EP2981829A4 (en) ANTI-MUCIN ANTIBODIES FOR EARLY DETECTION AND TREATMENT OF PANCREATIC CANCER
EP2861992A4 (en) PROCEDURE FOR HEAD AND NECK CANCER PROGNOSIS
GB2535914B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
HK1213634A1 (zh) 檢測癌症的方法
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
EP2802862A4 (en) SYSTEM AND METHODS FOR PLASMON RESONANCE MERCURY DETECTION OF LOCALIZED SURFACE
GB201221124D0 (en) Method of spectral data detection and manipulation
HK1200502A1 (en) Method for determining prognosis of prostate cancer in a subject
EP2972376A4 (en) Methods for determining prognosis of colorectal cancer
EP3060914A4 (en) Methods of determining breast cancer prognosis
EP2906954A4 (en) METHOD AND KITS FOR THE PROGNOSIS OF CANCER USING SOLUBLE MORTALINE IN THE BLOOD
EP2997378A4 (en) Method for determining prognosis of cancer